Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1998-03-02
2000-12-19
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514361, 548128, 548130, A61K 3141, C07D28568
Patent
active
061627917
ABSTRACT:
Novel 1,2,4-thiadiazole compounds are provided, which are effective as inhibitors of cysteine activity-dependent enzymes and in particular of cysteine proteases. The compounds are useful in treating acne by inhibition of transglutaminase, common cold by inhibition of human rhinovirus 3C protease and inflammatory joint disease by inhibition of cathepsins. The compounds of the present invention are 3,5-disubstituted 1,2,4-thiadazole of the general formula (I): ##STR1## where Z is a nitrogen containing group with recognition sequence for the enzyme and Y is a substituent that tunes the reactivity of the inhibitor towards the thiol group of the cysteine activity-dependent enzyme. The Y group may also serve in recognition.
REFERENCES:
patent: 5036085 (1991-07-01), Heinemann
Karimian Khashayar
Leung-Toung Regis C. S. H.
Li Wanren
Tam Tim Fat
Apotex Inc.
Gerstl Robert
LandOfFree
Thiadiazole compounds useful as inhibitors of cysteine activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thiadiazole compounds useful as inhibitors of cysteine activity , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thiadiazole compounds useful as inhibitors of cysteine activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-271364